Halberd Co. (OTCMKTS:HALB) Sees Significant Decrease in Short Interest

Halberd Co. (OTCMKTS:HALB) was the target of a significant decrease in short interest in December. As of December 31st, there was short interest totalling 700 shares, a decrease of 96.9% from the December 15th total of 22,300 shares. Based on an average trading volume of 1,645,800 shares, the days-to-cover ratio is currently 0.0 days.

Halberd Trading Up 4.9 %

Shares of HALB stock traded up $0.00 on Monday, hitting $0.00. The stock had a trading volume of 528,603 shares, compared to its average volume of 297,600. Halberd has a 12-month low of $0.00 and a 12-month high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.